Logo do repositório
 
A carregar...
Miniatura
Publicação

New 4-(N-cinnamoylbutyl)aminoacridines as potential multi-stage antiplasmodial leads

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
New_4.pdf2.21 MBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

A novel family of 4-aminoacridine derivatives was obtained by linking this heteroaromatic core to different trans-cinnamic acids. The 4-(N-cinnamoylbutyl)aminoacridines obtained exhibited in vitro activity in the low- or sub-micromolar range against (i) hepatic stages of Plasmodium berghei, (ii) erythrocytic forms of Plasmodium falciparum, and (iii) early and mature gametocytes of Plasmodium falciparum. The most active compound, having a meta-fluorocinnamoyl group linked to the acridine core, was 20- and 120-fold more potent, respectively, against the hepatic and gametocyte stages of Plasmodium infection than the reference drug, primaquine. Moreover, no cytotoxicity towards mammalian and red blood cells at the concentrations tested was observed for any of the compounds under investigation. These novel conjugates represent promising leads for the development of new multi-target antiplasmodials.

Descrição

© 2023 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Palavras-chave

Acridine Antimalarial Blood-stage Cinnamic acid Gametocyte Hybrid Liver-stage Multi-target

Contexto Educativo

Citação

Eur J Med Chem. 2023 Oct 5;258:115575

Projetos de investigação

Unidades organizacionais

Fascículo